A Review of Potential Antiviral Drugs and Vaccines to Treat COVID-19
Coronavirus disease 19 (COVID-19) is a challenge to the whole humanity. COVID-19 was first reported in China and rigorous researches are going on for developing vaccine for the pandemic. This review was prepared by following PRISMA guidelines and used the resources from the Web of Science and PubM...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Journal of Pure and Applied Microbiology
2020-05-01
|
Series: | Journal of Pure and Applied Microbiology |
Subjects: | |
Online Access: | https://microbiologyjournal.org/a-review-of-potential-antiviral-drugs-and-vaccines-to-treat-covid-19/ |
_version_ | 1798028931990814720 |
---|---|
author | Sanjeet Singh R. Jayaram |
author_facet | Sanjeet Singh R. Jayaram |
author_sort | Sanjeet Singh |
collection | DOAJ |
description | Coronavirus disease 19 (COVID-19) is a challenge to the whole humanity. COVID-19 was first reported
in China and rigorous researches are going on for developing vaccine for the pandemic. This review was
prepared by following PRISMA guidelines and used the resources from the Web of Science and PubMed.
This research focuses on the niches of symptoms and vaccines for COVID-19. The research for vaccine
involves research for new vaccine and drug repurposing. Out of various drug repurposing options,
Remdesivir, and Favipiravir, Chloroquine and Lopinavir/Ritonavir were found to be the popular ones
for treating COVID-19 patients across the world. Even though there are concerns regarding asymptotic
patients, the most dominant symptoms of COVID-19 are fever and cough, followed by Dyspnoea and
muscle ache. This review concludes that the COVID-19 related research should focus on developing
immunity vaccines, and repurposing of drugs. Research on the problems of quarantine life, patient
monitoring, and usage of information technology in facing COVID-19 will improve the quality of patient
handling during the pandemic. The research on the effectiveness of various models of lockdown and
regulation of social life during lockdown periods, improving the safety of health care workers in the
workplace will definitely help the governments in their fight against COVID-19. |
first_indexed | 2024-04-11T19:16:24Z |
format | Article |
id | doaj.art-1dc931f142904e299e494f81cd652c3d |
institution | Directory Open Access Journal |
issn | 0973-7510 2581-690X |
language | English |
last_indexed | 2024-04-11T19:16:24Z |
publishDate | 2020-05-01 |
publisher | Journal of Pure and Applied Microbiology |
record_format | Article |
series | Journal of Pure and Applied Microbiology |
spelling | doaj.art-1dc931f142904e299e494f81cd652c3d2022-12-22T04:07:25ZengJournal of Pure and Applied MicrobiologyJournal of Pure and Applied Microbiology0973-75102581-690X2020-05-0114suppl 176577410.22207/JPAM.14.SPL1.14A Review of Potential Antiviral Drugs and Vaccines to Treat COVID-19Sanjeet Singh0https://orcid.org/0000-0001-6103-2346R. Jayaram1https://orcid.org/0000-0002-8665-2944University Centre for Research and Development, Chandigarh University, NH-95, Ludhiana - Chandigarh State Highway, Punjab - 140 413, India.University Centre for Research and Development, Chandigarh University, NH-95, Ludhiana - Chandigarh State Highway, Punjab - 140 413, India.Coronavirus disease 19 (COVID-19) is a challenge to the whole humanity. COVID-19 was first reported in China and rigorous researches are going on for developing vaccine for the pandemic. This review was prepared by following PRISMA guidelines and used the resources from the Web of Science and PubMed. This research focuses on the niches of symptoms and vaccines for COVID-19. The research for vaccine involves research for new vaccine and drug repurposing. Out of various drug repurposing options, Remdesivir, and Favipiravir, Chloroquine and Lopinavir/Ritonavir were found to be the popular ones for treating COVID-19 patients across the world. Even though there are concerns regarding asymptotic patients, the most dominant symptoms of COVID-19 are fever and cough, followed by Dyspnoea and muscle ache. This review concludes that the COVID-19 related research should focus on developing immunity vaccines, and repurposing of drugs. Research on the problems of quarantine life, patient monitoring, and usage of information technology in facing COVID-19 will improve the quality of patient handling during the pandemic. The research on the effectiveness of various models of lockdown and regulation of social life during lockdown periods, improving the safety of health care workers in the workplace will definitely help the governments in their fight against COVID-19.https://microbiologyjournal.org/a-review-of-potential-antiviral-drugs-and-vaccines-to-treat-covid-19/covid-19coronavirusvaccinepandemicsars-cov-2 |
spellingShingle | Sanjeet Singh R. Jayaram A Review of Potential Antiviral Drugs and Vaccines to Treat COVID-19 Journal of Pure and Applied Microbiology covid-19 coronavirus vaccine pandemic sars-cov-2 |
title | A Review of Potential Antiviral Drugs and Vaccines to Treat COVID-19 |
title_full | A Review of Potential Antiviral Drugs and Vaccines to Treat COVID-19 |
title_fullStr | A Review of Potential Antiviral Drugs and Vaccines to Treat COVID-19 |
title_full_unstemmed | A Review of Potential Antiviral Drugs and Vaccines to Treat COVID-19 |
title_short | A Review of Potential Antiviral Drugs and Vaccines to Treat COVID-19 |
title_sort | review of potential antiviral drugs and vaccines to treat covid 19 |
topic | covid-19 coronavirus vaccine pandemic sars-cov-2 |
url | https://microbiologyjournal.org/a-review-of-potential-antiviral-drugs-and-vaccines-to-treat-covid-19/ |
work_keys_str_mv | AT sanjeetsingh areviewofpotentialantiviraldrugsandvaccinestotreatcovid19 AT rjayaram areviewofpotentialantiviraldrugsandvaccinestotreatcovid19 AT sanjeetsingh reviewofpotentialantiviraldrugsandvaccinestotreatcovid19 AT rjayaram reviewofpotentialantiviraldrugsandvaccinestotreatcovid19 |